
  
    
      
        Background_NNP
        RNA_NNP viruses_NNS are_VBP important_JJ pathogens_NNS in_IN humans_NNS ,_, animals_NNS ,_,
        and_CC plants_NNS ._. Their_PRP$ short_JJ generation_NN time_NN and_CC high_JJ mutation_NN
        rates_NNS allow_VBP them_PRP to_TO adapt_VB rapidly_RB to_TO changing_VBG environmental_JJ
        conditions_NNS ,_, and_CC make_VB them_PRP ever-changing_JJ targets_NNS for_IN
        anti-viral_JJ therapies_NNS or_CC vaccinations_NNS ._. RNA_NNP viruses_NNS form_VBP
        highly_RB polymorphic_JJ clouds_NNS of_IN mutants_NNS ,_, so-called_JJ
        quasispecies_NNS [_NN 1_CD 2_CD 3_CD ]_NN ._. At_IN viral_JJ loads_NNS of_IN 10_CD 8_CD or_CC more_JJR
        virions_NNS in_IN an_DT infected_JJ host_NN ,_, viral_JJ quasispecies_NNS 
        in_IN vivo_NN often_RB contain_VB all_DT possible_JJ
        single-point_JJ mutants_NNS from_IN the_DT consensus_NN sequence_NN ,_, as_RB well_RB
        as_IN a_DT sizeable_JJ fraction_NN of_IN two-_NN or_CC three-point_JJ mutants_NNS [_NN 4_CD ]_NN
        ._. Besides_IN their_PRP$ importance_NN as_IN pathogens_NNS ,_, RNA_NNP viruses_NNS have_VBP
        in_IN recent_JJ years_NNS also_RB become_VBP one_CD of_IN the_DT main_JJ tools_NNS for_IN
        experimental_JJ verification_NN of_IN theoretical_JJ population_NN
        genetics_NNS and_CC evolutionary_JJ theory_NN in_IN general_JJ (_( reviewed_VBN in_IN [_NN
        3_CD ]_NN )_) ._. This_DT line_NN of_IN research_NN can_MD draw_VB on_IN a_DT substantial_JJ body_NN
        of_IN literature_NN on_IN the_DT theory_NN of_IN quasispecies_NNS dynamics_NNS and_CC
        its_PRP$ relation_NN to_TO standard_JJ population_NN genetics_NNS [_NN 5_CD 6_CD 7_CD 8_CD 9_CD 10_CD
        11_CD 12_CD 13_CD 14_CD 15_CD 16_CD ]_NN ._.
        The_DT quasispecies_NNS theory_NN has_VBZ been_VBN useful_JJ to_TO understand_VB
        RNA_NNP virus_NN evolution_NN ,_, but_CC the_DT assumptions_NNS underlying_VBG the_DT
        model_NN do_VBP not_RB always_RB reflect_VB the_DT biology_NN of_IN RNA_NNP viruses_NNS ._. In_IN
        some_DT instances_NNS the_DT original_JJ model_NN has_VBZ been_VBN corrected_VBN to_TO
        account_VB for_IN discrepancies_NNS ,_, such_JJ as_IN infinite_NN vs_NNS ._. finite_JJ
        population_NN sizes_NNS [_NN 7_CD 9_CD 16_CD ]_NN ._. However_RB ,_, other_JJ factors_NNS need_VBP
        to_TO be_VB considered_VBN as_RB well_RB ._. For_IN instance_NN ,_, the_DT standard_JJ
        quasispecies_NNS model_NN assumes_VBZ low_JJ multiplicity_NN of_IN infection_NN
        (_( m_NN ._. o_NN ._. i_NNP ._. )_) ,_, that_WDT is_VBZ ,_, each_DT cell_NN is_VBZ assumed_VBN to_TO be_VB infected_VBN by_IN
        at_IN most_JJS one_CD virion_NN ._. At_IN high_JJ m_NN ._. o_NN ._. i_NNP ._. ,_, when_WRB several_JJ virions_NNS
        coinfect_NN a_DT single_JJ cell_NN ,_, the_DT virions_NNS can_MD recombine_NN [_NN 17_CD 18_CD
        19_CD ]_NN or_CC reassort_NN (_( for_IN segmented_JJ viruses_NNS )_) [_NN 20_CD 21_CD 22_CD 23_CD 24_CD
        25_CD ]_NN ._. Second_JJ ,_, the_DT model_NN assumes_VBZ that_IN the_DT genotype_NN of_IN a_DT
        virion_NN fully_RB determines_VBZ its_PRP$ fitness_NN ._. However_RB ,_, this_DT
        assumption_NN is_VBZ not_RB always_RB justified_JJ ,_, since_IN many_JJ viral_JJ
        functions_NNS can_MD be_VB provided_VBN in_IN trans_NNS -_: an_DT effect_NN referred_VBD to_TO
        as_IN complementation_NN ._. Thus_RB ,_, the_DT phenotype_NN of_IN a_DT virion_NN may_MD not_RB
        reflect_VB its_PRP$ genotype_NN [_NN 26_CD 27_CD 28_CD 29_CD ]_NN ._. Phenotypic_NNP mixing_VBG
        and_CC hiding_VBG is_VBZ a_DT particular_JJ case_NN of_IN complementation_NN
        involving_VBG surface_NN proteins_NNS (_( above_IN citations_NNS )_) ._. It_PRP occurs_VBZ
        either_CC at_IN high_JJ m_NN ._. o_NN ._. i_NNP ._. ,_, when_WRB two_CD or_CC more_RBR different_JJ mutants_NNS
        or_CC virus_NN strains_NNS freely_RB exchange_VBP genetic_JJ sequences_NNS and_CC
        surface_NN proteins_NNS inside_IN a_DT cell_NN ,_, or_CC at_IN low_JJ m_NN ._. o_NN ._. i_NNP ._. ,_, when_WRB a_DT
        mutant_JJ offspring_NN is_VBZ encapsidated_JJ by_IN its_PRP$ parent_NN 's_POS
        proteins_NNS ._.
        No_DT general_JJ theory_NN is_VBZ available_JJ for_IN the_DT evolutionary_JJ
        dynamic_NN of_IN a_DT viral_JJ quasispecies_NNS under_IN the_DT influence_NN of_IN
        virus_NN density_NN as_IN it_PRP changes_VBZ with_IN changing_VBG m_NN ._. o_NN ._. i_NNP ._. However_RB ,_,
        some_DT particular_JJ cases_NNS have_VBP been_VBN studied_VBN [_NN 30_CD 31_CD 32_CD ]_NN ,_,
        mostly_RB related_VBN to_TO recombination_NN and_CC reassortment_NN [_NN 33_CD 34_CD 35_CD
        36_CD ]_NN and_CC to_TO the_DT dynamic_NN of_IN defective_JJ interfering_VBG particles_NNS
        [_NN 37_CD 38_CD 39_CD 40_CD 41_CD ]_NN ._. In_IN this_DT paper_NN ,_, we_PRP modify_VB the_DT
        quasispecies_NNS model_NN by_IN incorporating_VBG phenotypic_JJ hiding_NN
        between_IN wild-type_JJ virus_NN and_CC a_DT deleterious_JJ mutant_JJ ._. We_PRP assume_VBP
        that_IN the_DT mutant_JJ differs_VBZ from_IN the_DT wild_JJ type_NN in_IN a_DT surface_NN
        protein_NN necessary_JJ for_IN cell_NN entry_NN ,_, so_IN that_IN the_DT fitness_NN
        difference_NN between_IN two_CD virions_NNS is_VBZ solely_RB determined_VBN by_IN the_DT
        surface_NN proteins_NNS ,_, and_CC not_RB by_IN the_DT particular_JJ genomes_NNS they_PRP
        carry_VBP ._. We_PRP show_VBP that_IN phenotypic_JJ hiding_NN of_IN the_DT mutant_JJ genome_NN
        behind_IN wild-type_JJ capsids_NNS increases_VBZ the_DT mutant_JJ frequency_NN
        above_IN the_DT level_NN predicted_VBN by_IN the_DT standard_JJ quasispecies_NNS
        model_NN ._. This_DT increase_NN in_IN mutant_JJ frequency_NN is_VBZ most_RBS pronounced_VBN
        at_IN high_JJ m_NN ._. o_NN ._. i_NNP ._. ,_, but_CC exists_VBZ also_RB at_IN very_RB low_JJ m_NN ._. o_NN ._. i_NNP ._.
        Moreover_RB ,_, we_PRP show_VBP that_IN the_DT decrease_NN of_IN mutant_JJ frequency_NN
        from_IN an_DT initially_RB high_JJ level_NN down_IN to_TO the_DT level_NN of_IN
        mutation-selection_JJ balance_NN is_VBZ slowed_VBN down_RB substantially_RB at_IN
        high_JJ m_NN ._. o_NN ._. i_NNP ._. because_IN of_IN phenotypic_JJ hiding_NN ._.
        We_PRP propose_VBP that_IN our_PRP$ model_NN may_MD explain_VB some_DT of_IN the_DT
        quantitative_JJ differences_NNS observed_VBD between_IN theoretical_JJ
        predictions_NNS of_IN the_DT quasispecies_NNS model_NN and_CC experimental_JJ data_NNS
        published_VBN in_IN the_DT literature_NN [_NN 42_CD 43_CD 44_CD 45_CD ]_NN ._.
        Foot-and-mouth_NNP disease_NN virus_NN (_( FMDV_NNP )_) has_VBZ been_VBN one_CD of_IN the_DT
        most_RBS productive_JJ models_NNS of_IN viral_JJ quasispecies_NNS dynamics_NNS
        (_( reviewed_VBN in_IN [_NN 46_CD ]_NN )_) ._. FMDV_NNP belongs_VBZ to_TO the_DT Picornaviridea_NNP
        family_NN ._. It_PRP has_VBZ a_DT non-segmented_JJ ,_, positive_JJ strand_NN genome_NN of_IN
        approximately_RB 8_CD ._. 5_CD Kb_NNP encapsidated_JJ by_IN viral_JJ proteins_NNS ,_, VP_NNP 1_CD ,_,
        VP_NNP 2_CD ,_, VP_NNP 3_CD and_CC VP_NNP 4_CD ._. A_DT conserved_JJ Arginine-_NNP Glycine-_NNP Aspartic_NNP
        acid_NN (_( RGD_NNP )_) triplet_NN in_IN βG-βH_JJ loop_NN of_IN VP_NNP 1_CD recognizes_VBZ the_DT
        αvβ_NN 3_CD ,_, αvβ_NN 6_CD or_CC αvβ_NN 1_CD integrin_NN as_IN viral_JJ receptor_NN (_( reviewed_VBN in_IN
        Ref_NNP ._. [_NN 47_CD ]_NN )_) ,_, the_DT first_JJ necessary_JJ step_NN for_IN virus_NN entry_NN ._.
        Work_NN carried_VBD out_IN with_IN different_JJ RGD_NNP virus_NN mutants_NNS and_CC mimic_VB
        peptides_NNS [_NN 48_CD 49_CD 50_CD 51_CD 52_CD ]_NN clearly_RB demonstrates_VBZ the_DT
        critical_JJ role_NN that_IN the_DT RGD_NNP triplet_NN has_VBZ in_IN virus_NN entry_NN ,_, and_CC
        its_PRP$ little_JJ tolerance_NN to_TO variation_NN ._. Among_IN the_DT few_JJ RGD_NNP
        mutants_NNS that_WDT have_VBP been_VBN isolated_VBN ,_, on_IN is_VBZ RED_NNP ,_, a_DT low_JJ fitness_NN
        mutant_JJ in_IN which_WDT the_DT glycine_NN is_VBZ replace_VB by_IN glutamic_JJ acid_NN [_NN
        53_CD ]_NN ._. Ruíz-_NNP Jarabo_NNP and_CC co-workers_NNS found_VBD that_IN after_IN
        revertant_NN RGD_NNP genomes_NNS became_VBD dominant_JJ ,_, and_CC mutant_JJ genomes_NNS
        were_VBD no_RB longer_RB detected_VBD in_IN the_DT consensus_NN sequence_NN ,_, RED_NNP was_VBD
        able_JJ to_TO remain_VB in_IN the_DT population_NN for_IN very_RB long_JJ times_NNS and_CC at_IN
        surprisingly_RB high_JJ frequencies_NNS [_NN 42_CD 43_CD 44_CD 45_CD ]_NN ._. There_EX is_VBZ a_DT
        qualitative_JJ agreement_NN between_IN the_DT predictions_NNS of_IN the_DT
        quasispecies_NNS model_NN and_CC this_DT result_NN ,_, but_CC there_EX is_VBZ also_RB a_DT
        quantitative_JJ discrepancy_NN ._. RED_NNP memory_NN genomes_NNS can_MD be_VB
        observed_VBN at_IN much_RB higher_JJR frequency_NN than_IN expected_VBN ._. However_RB ,_,
        phenotypic_JJ hiding_NN promotes_VBZ a_DT decelerated_VBN decay_NN of_IN mutant_JJ
        genomes_NNS in_IN the_DT population_NN ,_, and_CC this_DT decelerated_VBN decay_NN could_MD
        be_VB interpreted_VBN as_IN a_DT memory_NN effect_NN ,_, in_IN agreement_NN with_IN the_DT
        results_NNS by_IN Ruíz-_NNP Jarabo_NNP et_CC al_NN ._. The_DT research_NN design_NN of_IN the_DT
        original_JJ work_NN [_NN 42_CD 43_CD 44_CD 45_CD ]_NN does_VBZ not_RB allow_VB us_PRP to_TO
        conclusively_RB accept_VB or_CC reject_VB our_PRP$ model_NN as_IN the_DT correct_JJ
        explanation_NN for_IN their_PRP$ observations_NNS ,_, but_CC the_DT values_NNS of_IN
        mutant_JJ frequencies_NNS predicted_VBN by_IN our_PRP$ model_NN are_VBP consistent_JJ
        with_IN the_DT experimental_JJ data_NN ._.
      
      
        Model_NNP
        We_PRP assume_VBP that_IN the_DT virus_NN is_VBZ propagated_JJ under_IN serial_NN
        transfer_NN ,_, and_CC model_VB the_DT change_NN in_IN mutant_JJ concentrations_NNS
        from_IN passage_NN to_TO passage_NN ._. We_PRP assume_VBP that_IN the_DT difference_NN
        between_IN wild_JJ type_NN and_CC mutant_JJ lies_NNS in_IN the_DT capsid_NN proteins_NNS ,_,
        such_JJ that_IN the_DT mutation_NN affects_VBZ the_DT ability_NN of_IN the_DT virus_NN to_TO
        enter_VB a_DT cell_NN ,_, but_CC not_RB the_DT viability_NN of_IN the_DT virus_NN inside_IN the_DT
        cell_NN ._. Under_IN phenotypic_JJ mixing_VBG and_CC hiding_VBG ,_, there_EX are_VBP four_CD
        types_NNS of_IN virions_NNS that_WDT can_MD occur_VB :_: wild-type_JJ genotype_NN with_IN
        wild-type_JJ phenotype_NN ,_, wild-type_JJ genotype_NN with_IN mutant_JJ
        phenotype_NN ,_, mutant_JJ genotype_NN with_IN wild-type_JJ phenotype_NN ,_, and_CC
        mutant_JJ genotype_NN with_IN mutant_JJ phenotype_NN ._. We_PRP will_MD call_VB virions_NNS
        whose_WP$ genotype_NN coincides_VBZ with_IN their_PRP$ phenotype_NN as_IN pure_JJ ,_, and_CC
        virions_NNS for_IN which_WDT genotype_NN and_CC phenotype_NN do_VBP not_RB coincide_VB as_IN
        mixed_JJ ._. In_IN the_DT following_VBG paragraphs_NNS ,_, we_PRP outline_VB the_DT
        derivation_NN of_IN a_DT set_NN of_IN deterministic_JJ equations_NNS that_WDT
        describe_VBP the_DT change_NN in_IN relative_JJ concentrations_NNS of_IN the_DT
        different_JJ pure_JJ and_CC mixed_JJ virions_NNS in_IN an_DT infinite_NN virus_NN
        population_NN ._. More_JJR details_NNS are_VBP given_VBN in_IN the_DT Methods_NNP section_NN ._.
        Our_PRP$ model_NN is_VBZ similar_JJ to_TO models_NNS studied_VBN by_IN Szathmáry_NNP [_NN 38_CD 39_CD
        ]_NN ._.
        The_DT probability_NN 
        p_NN 
        
          ww_NN 
         that_IN an_DT offspring_NN virion_NN is_VBZ pure_JJ wild_JJ type_NN is_VBZ 
        p_NN 
        
          ww_NN 
         =_SYM (_( 1_CD -_: 
        r_LS )_) 
        x_SYM 
        
          w_NN 
         +_NN 
        r_LS [_NN Methods_NNP section_NN ,_, Eq_NNP ._. (_( 14_CD )_) ]_NN ,_, where_WRB 
        x_SYM 
        
          w_NN 
         is_VBZ the_DT probability_NN with_IN which_WDT a_DT particular_JJ virion_NN that_IN
        infects_NNS a_DT cell_NN contains_VBZ the_DT wild-type_JJ genome_NN ,_, and_CC 
        r_LS is_VBZ a_DT parameter_NN related_VBN to_TO the_DT
        multiplicity_NN of_IN infection_NN ._. Likewise_RB ,_, the_DT probabilities_NNS 
        p_NN 
        
          wm_NN 
         and_CC 
        p_NN 
        
          mw_NN 
         that_IN an_DT offspring_NN virion_NN is_VBZ mixed_VBN of_IN either_DT type_NN are_VBP 
        p_NN 
        
          wm_NN 
         =_SYM 
        p_NN 
        
          mw_NN 
         =_SYM 
        rx_NN 
        
          w_NN 
         
        x_SYM 
        
          m_NN 
         [_NN Eq_NNP ._. (_( 15_CD )_) ]_NN ,_, where_WRB 
        x_SYM 
        
          m_NN 
         =_SYM 1_CD -_: 
        x_SYM 
        
          w_NN 
         ,_, and_CC the_DT probability_NN 
        p_NN 
        
          mm_NN 
         that_IN an_DT offspring_NN virion_NN is_VBZ pure_JJ mutant_JJ is_VBZ 
        p_NN 
        
          mm_NN 
         =_SYM (_( 1_CD -_: 
        r_LS )_) 
        x_SYM 
        
          m_NN 
         +_NN 
        r_LS ._. The_DT formula_NN that_WDT relates_VBZ the_DT
        parameter_NN 
        r_LS to_TO the_DT multiplicity_NN of_IN infection_NN ,_,
        Eq_NNP ._. (_( 13_CD )_) ,_, is_VBZ somewhat_RB unwieldy_JJ ._. For_IN reference_NN ,_, and_CC in_IN order_NN
        to_TO provide_VB an_DT intuitive_JJ meaning_NN for_IN 
        r_LS ,_, we_PRP have_VBP tabulated_JJ 
        r_LS (_( which_WDT we_PRP will_MD call_VB in_IN the_DT
        following_VBG also_RB the_DT mixing_VBG parameter_NN )_) versus_CC the_DT m_NN ._. o_NN ._. i_NNP ._. in_IN
        Table_NNP 1_CD ._.
        The_DT probabilities_NNS 
        x_SYM 
        
          w_NN 
         and_CC 
        x_SYM 
        
          m_NN 
         depend_VB on_IN the_DT composition_NN of_IN the_DT types_NNS of_IN free_JJ virions_NNS
        on_IN infection_NN ._. Assume_VB that_DT 
        y_NN 
        
          ww_NN 
         is_VBZ the_DT concentration_NN of_IN pure_JJ wild-type_JJ virions_NNS at_IN
        passage_NN 
        t_NN ,_, 
        y_NN 
        
          wm_NN 
         that_IN of_IN mixed_VBN virions_NNS with_IN wild-type_JJ genotype_NN and_CC
        mutant_JJ phenotype_NN ,_, 
        y_NN 
        
          mw_NN 
         that_IN of_IN mixed_VBN virions_NNS with_IN mutant_JJ genotype_NN and_CC
        wild-type_JJ phenotype_NN ,_, and_CC 
        y_NN 
        
          mm_NN 
         that_IN of_IN pure_JJ mutant_JJ virions_NNS ._. Further_RB ,_, assume_VB that_IN
        virions_NNS with_IN wild-type_JJ phenotype_NN infect_NN cells_NNS at_IN a_DT rate_NN γ_NN 
        
          w_NN 
         ,_, while_IN virions_NNS with_IN mutant_JJ phenotype_NN infect_NN at_IN a_DT rate_NN
        γ_NN 
        
          m_NN 
         <_NN γ_NN 
        
          w_NN 
         ._. Then_RB ,_, the_DT total_JJ rate_NN at_IN which_WDT cells_NNS are_VBP infected_VBN
        with_IN wild-type_JJ genomes_NNS is_VBZ γ_NN 
        
          w_NN 
         
        y_NN 
        
          ww_NN 
         +_NN γ_NN 
        
          m_NN 
         
        y_NN 
        
          wm_NN 
         ._. Likewise_RB ,_, the_DT total_JJ rate_NN at_IN which_WDT cells_NNS are_VBP infected_VBN
        with_IN mutant_JJ genomes_NNS is_VBZ γ_NN 
        
          w_NN 
         
        y_NN 
        
          mw_NN 
         +_NN γ_NN 
        
          m_NN 
         
        y_NN 
        
          mm_NN 
         ._. Therefore_RB ,_, we_PRP have_VBP 
        x_SYM 
        
          w_NN 
         =_SYM (_( γ_NN 
        
          w_NN 
         y_NN 
        
          ww_NN 
         +_NN γ_NN 
        
          m_NN 
         
        y_NN 
        
          wm_NN 
         )_) /_NN [_NN γ_NN 
        
          m_NN 
         (_( 
        y_NN 
        
          wm_NN 
         +_NN 
        y_NN 
        
          mm_NN 
         )_) ]_NN ._. The_DT probability_NN 
        x_SYM 
        
          m_NN 
         follows_VBZ from_IN 
        x_SYM 
        
          m_NN 
         =_SYM 1_CD -_: 
        x_SYM 
        
          w_NN 
         ._.
        Using_VBG the_DT various_JJ formulas_NNS given_VBN in_IN the_DT previous_JJ two_CD
        paragraphs_NNS ,_, we_PRP find_VBP that_IN the_DT virion_NN concentrations_NNS at_IN
        passage_NN 
        t_NN +_NN 1_CD (_( primed_VBN quantities_NNS )_) are_VBP given_VBN
        by_IN
        
        We_PRP now_RB introduce_VB mutations_NNS into_IN this_DT model_NN ._. We_PRP assume_VBP
        that_IN the_DT wild_JJ type_NN mutates_NNS into_IN the_DT mutant_JJ with_IN probability_NN
        μ_NN ._. For_IN simplicity_NN ,_, we_PRP assume_VBP that_IN back_JJ mutations_NNS occur_VBP at_IN
        the_DT same_JJ rate_NN ._. (_( It_PRP is_VBZ safe_JJ to_TO make_VB this_DT assumption_NN ,_, because_IN
        the_DT rate_NN of_IN back_JJ mutations_NNS from_IN deleterious_JJ to_TO advantageous_JJ
        mutants_NNS tends_VBZ to_TO have_VB little_JJ effect_NN on_IN mutation-selection_JJ
        balance_NN ._. )_) Mutations_NNP will_MD typically_RB not_RB affect_VB the_DT phenotype_NN
        of_IN the_DT offspring_NN virion_NN ,_, which_WDT is_VBZ determined_VBN by_IN the_DT
        distribution_NN of_IN mutant_JJ or_CC wild-type_JJ capsid_NN proteins_NNS in_IN the_DT
        cell_NN ._. The_DT extended_VBN model_NN with_IN mutations_NNS therefore_RB
        becomes_VBZ
        
      
      
        Results_NNS
        
          Extinction_NNP of_IN mutant_JJ for_IN μ_NN =_SYM 0_CD
          In_IN order_NN to_TO evaluate_VB whether_IN the_DT mutant_JJ can_MD coexist_NN
          with_IN the_DT wild_JJ type_NN or_CC will_MD ultimately_RB go_VB extinct_JJ if_IN it_PRP is_VBZ
          not_RB constantly_RB regenerated_JJ through_IN mutations_NNS ,_, we_PRP have_VBP to_TO
          analyze_VB the_DT fixed_VBN points_NNS of_IN Eqs_NNP ._. (_( 1_CD a_DT )_) -_: (_( 1_CD d_SYM )_) ._. There_EX are_VBP two_CD
          trivial_JJ fixed_VBN points_NNS ,_, corresponding_JJ to_TO the_DT cases_NNS in_IN which_WDT
          all_DT virions_NNS are_VBP either_CC pure_JJ wild-type_JJ or_CC pure_JJ mutant_JJ ._. We_PRP
          could_MD not_RB find_VB any_DT non-trivial_JJ fixed_VBN points_NNS ._. Since_IN the_DT
          expressions_NNS involved_VBN are_VBP extremely_RB unwieldy_JJ ,_, we_PRP searched_VBD
          for_IN non-trivial_JJ fixed_VBN points_NNS only_RB numerically_RB (_( using_VBG the_DT
          function_NN NSolve_NNP of_IN Mathematica_NNP [_NN 54_CD ]_NN )_) ._.
          A_DT linear_JJ expansion_NN around_IN the_DT fixed_VBN points_NNS tells_VBZ us_PRP
          whether_IN the_DT mutant_JJ can_MD invade_VB an_DT established_VBN wild-type_JJ
          population_NN or_CC vice_NN versa_RB ._. If_IN we_PRP introduce_VB a_DT small_JJ amount_NN
          ε_NN of_IN mutant_JJ virions_NNS into_IN an_DT established_VBN wild-type_JJ
          population_NN ,_, the_DT total_JJ amounts_NNS of_IN wild-type_JJ genomes_NNS 
          Y_NNP 
          
            w_NN 
           =_SYM 
          y_NN 
          
            ww_NN 
           +_NN 
          y_NN 
          
            wm_NN 
           and_CC mutant_JJ genomes_NNS 
          Y_NNP 
          
            m_NN 
           =_SYM 
          y_NN 
          
            mm_NN 
           +_NN 
          y_NN 
          
            mw_NN 
           after_IN the_DT next_JJ passage_NN become_VB to_TO first_JJ order_NN in_IN
          ε_NN :_:
          
          As_RB long_RB as_IN γ_NN 
          
            m_NN 
           /_NN γ_NN 
          
            w_NN 
           <_NN 1_CD (_( as_IN we_PRP assume_VBP throughout_IN this_DT paper_NN )_) ,_, the_DT
          amount_NN of_IN mutant_JJ genomes_NNS in_IN the_DT population_NN decreases_NNS in_IN
          the_DT first_JJ passage_NN ,_, which_WDT implies_VBZ that_IN the_DT mutant_JJ cannot_NN
          invade_VB ._. Likewise_RB ,_, if_IN we_PRP introduce_VB a_DT small_JJ amount_NN ε_NN of_IN
          wild-type_JJ virions_NNS into_IN an_DT established_VBN mutant_JJ population_NN ,_,
          the_DT total_JJ amounts_NNS of_IN mutant_JJ and_CC wild-type_JJ genomes_NNS after_IN
          the_DT next_JJ passage_NN become_VB to_TO first_JJ order_NN in_IN ε_NN :_:
          
          In_IN this_DT case_NN ,_, the_DT amount_NN of_IN the_DT invading_VBG wild-type_JJ
          genomes_NNS in_IN the_DT population_NN increases_NNS ,_, which_WDT implies_VBZ that_IN
          the_DT wild-type_JJ can_MD invade_VB an_DT established_VBN mutant_JJ
          population_NN ._. The_DT invasion_NN of_IN a_DT mutant_JJ population_NN by_IN a_DT
          small_JJ amount_NN of_IN wild-type_JJ virions_NNS is_VBZ shown_VBN in_IN Fig_NNP ._. 1_LS ._.
          The_DT preceeding_VBG analysis_NN shows_VBZ that_DT Eqs_NNP ._. (_( 1_CD a_DT )_) -_: (_( 1_CD d_SYM )_) have_VBP
          only_RB a_DT single_JJ stable_JJ fixed_VBN point_NN ,_, the_DT one_CD in_IN which_WDT the_DT
          whole_JJ population_NN consists_VBZ of_IN pure_JJ wild-type_JJ virions_NNS ._. The_DT
          mutant_JJ will_MD therefore_RB always_RB go_VB extinct_JJ eventually_RB ._.
          The_DT rate_NN at_IN which_WDT the_DT mutant_JJ disappears_VBZ depends_VBZ on_IN the_DT
          m_NN ._. o_NN ._. i_NNP ._. Figure_NN 2_CD shows_VBZ the_DT ratio_NN between_IN mutant_JJ and_CC
          wild-type_JJ concentrations_NNS as_IN a_DT function_NN of_IN passage_NN ,_, for_IN
          various_JJ m_NN ._. o_NN ._. i_NNP ._. Concentrations_NNP are_VBP measured_VBN with_IN respect_NN
          to_TO the_DT genotype_NN ,_, that_WDT is_VBZ ,_, mutant_JJ and_CC wild-type_JJ
          concentrations_NNS are_VBP 
          Y_NNP 
          
            m_NN 
           and_CC 
          Y_NNP 
          
            w_NN 
           ,_, respectively_RB ._. In_IN the_DT example_NN given_VBN ,_, we_PRP have_VBP γ_NN 
          
            m_NN 
           /_NN γ_NN 
          
            w_NN 
           =_SYM 0_CD ._. 3_CD ._. At_IN low_JJ m_NN ._. o_NN ._. i_NNP ._. ,_, the_DT mutant-to-wild-type_JJ ratio_NN
          drops_NNS from_IN 1_CD at_IN passage_NN zero_CD to_TO values_NNS of_IN 10_CD -_: 2_CD and_CC lower_JJR
          after_IN four_CD passages_NNS ._. At_IN high_JJ m_NN ._. o_NN ._. i_NNP ._. ,_, the_DT reduction_NN in_IN
          mutant_JJ concentration_NN proceeds_NNS much_RB slower_JJR ._. For_IN example_NN ,_,
          at_IN an_DT m_NN ._. o_NN ._. i_NNP ._. of_IN three_CD ,_, the_DT mutant-to-wild-type_JJ ratio_NN is_VBZ
          only_RB 10_CD -_: 1_CD after_IN four_CD passages_NNS ._. An_DT interesting_JJ aspect_NN of_IN
          Fig_NNP ._. 2_LS is_VBZ that_IN the_DT reduction_NN in_IN mutant_JJ frequency_NN during_IN
          the_DT first_JJ passage_NN is_VBZ independent_JJ of_IN the_DT m_NN ._. o_NN ._. i_NNP ._. This_DT
          effect_NN is_VBZ a_DT consequence_NN of_IN our_PRP$ assumption_NN that_IN the_DT mutant_JJ
          has_VBZ impaired_VBN ability_NN of_IN cell_NN entry_NN ._. In_IN the_DT first_JJ round_NN of_IN
          infection_NN ,_, when_WRB all_DT virions_NNS are_VBP pure_JJ wild_JJ type_NN or_CC pure_JJ
          mutant_JJ ,_, the_DT mutant_JJ virions_NNS cannot_NN benefit_NN from_IN phenotypic_JJ
          hiding_NN ._. Therefore_RB ,_, their_PRP$ frequency_NN will_MD decrease_VB
          corresponding_JJ to_TO the_DT true_JJ fitness_NN difference_NN to_TO the_DT wild_JJ
          type_NN ,_, independent_JJ of_IN the_DT m_NN ._. o_NN ._. i_NNP ._. From_IN the_DT second_JJ passage_NN
          onward_NN ,_, the_DT balance_NN between_IN pure_JJ and_CC mixed_JJ virions_NNS is_VBZ
          established_VBN ,_, and_CC further_JJ reduction_NN of_IN the_DT mutant_JJ
          frequency_NN is_VBZ slowed_VBN down_RB at_IN high_JJ m_NN ._. o_NN ._. i_NNP ._.
          Figure_NN 3_CD shows_VBZ the_DT individual_JJ concentrations_NNS of_IN the_DT
          various_JJ pure_JJ and_CC mixed_JJ virions_NNS at_IN an_DT m_NN ._. o_NN ._. i_NNP ._. of_IN five_CD ._. We_PRP
          observe_VBP that_IN the_DT concentration_NN of_IN pure_JJ mutant_JJ virions_NNS
          decreases_NNS much_JJ faster_RBR than_IN that_DT of_IN mixed_VBN virions_NNS with_IN
          mutant_JJ genomes_NNS ._. After_IN ten_CD passages_NNS both_DT concentrations_NNS
          are_VBP equal_JJ ,_, and_CC after_IN fifty_NN passages_NNS ,_, there_EX are_VBP more_RBR than_IN
          twice_RB as_IN many_JJ mixed_VBN virions_NNS with_IN mutant_JJ genomes_NNS than_IN
          there_EX are_VBP pure_JJ mutant_JJ virions_NNS ._. When_WRB the_DT mutant_JJ is_VBZ rare_JJ ,_,
          it_PRP is_VBZ mostly_RB hiding_VBG behind_IN wild-type_JJ capsids_NNS ,_, which_WDT slows_VBZ
          down_RP its_PRP$ extinction_NN ._. Interestingly_RB ,_, the_DT fraction_NN of_IN
          mutant_JJ genomes_NNS encapsidated_JJ with_IN wild-type_JJ protein_NN is_VBZ
          equal_JJ to_TO the_DT fraction_NN of_IN wild-type_JJ genomes_NNS encapsidated_JJ
          with_IN mutant_JJ protein_NN at_IN zero_CD mutation_NN rate_NN ._. This_DT symmetry_NN
          is_VBZ a_DT consequence_NN of_IN the_DT symmetry_NN of_IN equations_NNS (_( 1_CD b_SYM )_) and_CC
          (_( 1_CD c_SYM )_) ,_, and_CC disappears_VBZ for_IN μ_NN >_NN 0_CD ._.
        
        
          Mutation-selection_NNP balance_NN for_IN positive_JJ μ_NN
          We_PRP now_RB turn_VBP to_TO the_DT general_JJ case_NN of_IN a_DT positive_JJ mutation_NN
          rate_NN μ_NN ._. We_PRP first_JJ consider_VB the_DT case_NN of_IN vanishingly_RB low_JJ
          m_NN ._. o_NN ._. i_NNP ._. ,_, 
          r_LS =_SYM 0_CD ._. When_WRB we_PRP set_VBD 
          r_LS =_SYM 0_CD ,_, Eq_NNP ._. (_( 2_LS )_) becomes_VBZ the_DT
          discrete-time_JJ version_NN of_IN a_DT model_NN of_IN maternal_NN effects_NNS in_IN
          quasispecies_NNS evolution_NN [_NN 55_CD ]_NN ._. In_IN Ref_NNP ._. [_NN 55_CD ]_NN ,_, the_DT
          fitness_NN of_IN a_DT virion_NN is_VBZ assumed_VBN to_TO be_VB the_DT product_NN of_IN a_DT
          contribution_NN from_IN the_DT genotype_NN of_IN the_DT virion_NN 's_POS parent_NN and_CC
          one_CD from_IN the_DT virion_NN 's_POS own_JJ genotype_NN ._. The_DT situation_NN here_RB is_VBZ
          simpler_JJR ,_, because_IN we_PRP assume_VBP that_DT fitness_NN is_VBZ only_RB
          determined_VBN by_IN the_DT phenotype_NN (_( efficiency_NN of_IN cell_NN entry_NN )_) ._.
          In_IN the_DT language_NN of_IN Ref_NNP ._. [_NN 55_CD ]_NN ,_, this_DT means_VBZ we_PRP have_VBP 
          b_SYM 
          
            i_NNP 
           =_SYM 1_CD for_IN all_DT genotypes_NNS 
          i_NNP ._. From_IN Eqs_NNP ._. (_( 5_LS )_) and_CC (_( 6_CD )_) in_IN Ref_NNP ._. [_NN
          55_CD ]_NN ,_, we_PRP obtain_VBP the_DT steady-state_JJ concentrations_NNS of_IN pure_JJ
          and_CC mixed_JJ virions_NNS (_( neglecting_VBG back_RB mutations_NNS from_IN mutant_JJ
          to_TO wild_JJ type_NN )_) :_:
          
          We_PRP mentioned_VBD in_IN the_DT previous_JJ section_NN that_DT 
          y_NN 
          
            wm_NN 
           =_SYM 
          y_NN 
          
            mw_NN 
           for_IN μ_NN =_SYM 0_CD ._. Clearly_RB ,_, this_DT symmetry_NN does_VBZ not_RB exist_VB for_IN
          μ_NN >_NN 0_CD ._. For_IN 0_CD <_NN μ_NN <_NN <_NN 1_CD ,_, the_DT ratio_NN in_IN
          concentration_NN of_IN the_DT two_CD classes_NNS of_IN mixed_JJ virions_NNS is_VBZ 
          y_NN 
          
            mw_NN 
           /_NN 
          y_NN 
          
            wm_NN 
           =_SYM (_( 1_CD -_: μ_NN -_: γ_NN 
          
            m_NN 
           /_NN γ_NN 
          
            w_NN 
           )_) /_NN μ_NN ≈_NN 1_CD /_NN μ_NN ._. There_EX will_MD typically_RB be_VB several_JJ orders_NNS of_IN
          magnitude_NN more_RBR mutant_JJ genomes_NNS encapsidated_JJ in_IN wild-type_JJ
          protein_NN than_IN wild-type_JJ genomes_NNS encapsidated_JJ in_IN mutant_JJ
          protein_NN ._. Note_VB ,_, however_RB ,_, that_IN this_DT result_NN holds_VBZ only_RB under_IN
          the_DT assumption_NN of_IN vanishingly_RB low_JJ m_NN ._. o_NN ._. i_NNP ._. As_IN the_DT m_NN ._. o_NN ._. i_NNP ._.
          increases_NNS ,_, the_DT mixed_VBN virions_NNS with_IN mutant_JJ genomes_NNS will_MD
          still_RB be_VB at_IN higher_JJR concentration_NN than_IN the_DT mixed_VBN virions_NNS
          with_IN wild-type_JJ genomes_NNS ,_, but_CC the_DT ratio_NN between_IN the_DT two_CD
          will_MD be_VB much_RB smaller_JJR than_IN 1_CD /_NN μ_NN ._. The_DT ratio_NN of_IN mixed_VBN virions_NNS
          with_IN mutant_JJ genomes_NNS to_TO pure_JJ mutant_JJ virions_NNS is_VBZ 
          y_NN 
          
            mw_NN 
           /_NN 
          y_NN 
          
            mm_NN 
           ≈_NN 1_CD -_: γ_NN 
          
            m_NN 
           /_NN γ_NN 
          
            w_NN 
           <_NN 1_CD at_IN low_JJ m_NN ._. o_NN ._. i_NNP ._. ,_, that_WDT is_VBZ ,_, there_EX are_VBP more_RBR pure_JJ
          virions_NNS than_IN mixed_VBN virions_NNS with_IN mutant_JJ genomes_NNS in_IN
          equilibrium_NN ._. We_PRP found_VBD numerically_RB that_IN at_IN high_JJ m_NN ._. o_NN ._. i_NNP ._. ,_,
          this_DT relationship_NN is_VBZ reversed_VBN ,_, and_CC there_EX are_VBP
          substantially_RB more_RBR mixed_JJ than_IN pure_JJ mutants_NNS ._.
          For_IN the_DT total_JJ amount_NN of_IN mutant_JJ genomes_NNS in_IN the_DT
          population_NN ,_, we_PRP obtain_VBP after_IN summing_VBG Eqs_NNP ._. (_( 5_CD c_SYM )_) and_CC
          (_( 5_CD d_SYM )_) :_:
          
          For_IN comparison_NN ,_, the_DT standard_JJ quasispecies_NNS model_NN
          (_( without_IN phenotypic_JJ hiding_NN )_) predicts_VBZ :_:
          
          This_DT expression_NN is_VBZ equivalent_JJ to_TO the_DT one_CD given_VBN by_IN
          Ruíz-_NNP Jarabo_NNP et_CC al_NN ._. in_IN their_PRP$ analysis_NN of_IN quasispecies_NNS
          memory_NN [_NN 44_CD ]_NN ._. Equations_NNP (_( 6_CD )_) and_CC (_( 7_CD )_) differ_VB only_RB in_IN the_DT
          factor_NN 2_CD (_( 1_CD -_: μ_NN )_) -_: γ_NN 
          
            m_NN 
           /_NN γ_NN 
          
            w_NN 
           ._. This_DT factor_NN is_VBZ larger_JJR than_IN one_CD for_IN small_JJ mutation_NN
          rates_NNS ,_, that_WDT is_VBZ ,_, as_RB long_RB as_IN
          μ_NN <_NN (_( 1_CD -_: γ_NN 
          
            m_NN 
           /_NN γ_NN 
          
            w_NN 
           )_) /_NN 2_CD ._. (_( 8_CD )_)
          If_IN the_DT mutant_JJ has_VBZ a_DT substantial_JJ fitness_NN disadvantage_NN
          in_IN comparison_NN to_TO the_DT wild_JJ type_NN (_( say_VBP at_IN least_JJS 10_CD %_NN )_) ,_, then_RB μ_NN
          will_MD always_RB be_VB small_JJ enough_RB to_TO satisfy_VB this_DT condition_NN ._.
          Therefore_RB ,_, phenotypic_JJ hiding_NN will_MD lead_VB to_TO an_DT increase_NN in_IN
          mutant_JJ genomes_NNS even_RB at_IN low_JJ m_NN ._. o_NN ._. i_NNP ._. The_DT increase_NN is_VBZ at_IN most_JJS
          a_DT factor_NN of_IN two_CD (_( for_IN μ_NN <_NN <_NN 1_CD and_CC γ_NN 
          
            m_NN 
           /_NN γ_NN 
          
            w_NN 
           <_NN <_NN 1_LS )_) in_IN comparison_NN to_TO the_DT prediction_NN of_IN the_DT
          standard_JJ quasispecies_NNS model_NN ._.
          For_IN the_DT case_NN of_IN positive_JJ mutation_NN rate_NN and_CC high_JJ
          m_NN ._. o_NN ._. i_NNP ._. ,_, there_EX is_VBZ no_DT analytic_JJ solution_NN available_JJ ,_, and_CC we_PRP
          have_VBP to_TO resort_VB to_TO numerical_JJ simulations_NNS ._. Figure_NN 4_CD shows_VBZ
          the_DT decay_NN of_IN mutant_JJ genomes_NNS over_IN time_NN ,_, starting_VBG from_IN an_DT
          initial_JJ state_NN where_WRB mutant_JJ and_CC wild_JJ type_NN are_VBP present_JJ in_IN
          equal_JJ concentrations_NNS ._. We_PRP have_VBP displayed_VBN trajectories_NNS for_IN
          a_DT wide_JJ range_NN of_IN m_NN ._. o_NN ._. i_NNP ._. ,_, and_CC we_PRP have_VBP also_RB displayed_VBN the_DT
          corresponding_JJ trajectory_NN generated_VBN by_IN the_DT standard_JJ
          quasispecies_NNS model_NN ._. All_DT trajectories_NNS show_VBP the_DT same_JJ
          qualitative_JJ behavior_NN :_: The_DT mutant_JJ frequency_NN decays_NNS quickly_RB
          during_IN the_DT initial_JJ passages_NNS ,_, and_CC then_RB levels_NNS off_RP in_IN
          mutation-selection_JJ balance_NN ._. As_IN discussed_VBN in_IN the_DT previous_JJ
          paragraphs_NNS ,_, the_DT level_NN of_IN mutant_JJ genomes_NNS in_IN
          mutation-selection_JJ balance_NN is_VBZ always_RB higher_JJR in_IN our_PRP$ model_NN
          than_IN in_IN the_DT standard_JJ quasispecies_NNS model_NN ._. Moreover_RB ,_, the_DT
          level_NN of_IN mutant_JJ genomes_NNS increases_NNS with_IN increasing_VBG m_NN ._. o_NN ._. i_NNP ._.
          The_DT initial_JJ decay_NN of_IN mutant_JJ genomes_NNS is_VBZ also_RB influenced_VBN by_IN
          the_DT m_NN ._. o_NN ._. i_NNP ._. ,_, and_CC slows_VBZ down_RB with_IN increasing_VBG m_NN ._. o_NN ._. i_NNP ._. In_IN
          general_JJ ,_, the_DT initial_JJ decay_NN of_IN mutant_JJ genomes_NNS for_IN μ_NN >_NN 0_CD
          is_VBZ identical_JJ to_TO the_DT one_CD for_IN μ_NN =_SYM 0_CD ,_, as_IN described_VBN in_IN the_DT
          previous_JJ subsection_NN ._. It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN
          phenotypic_JJ hiding_NN influences_VBZ the_DT equilibrium_NN
          concentration_NN of_IN mutant_JJ genomes_NNS at_IN low_JJ m_NN ._. o_NN ._. i_NNP ._. ,_, but_CC not_RB
          the_DT speed_NN at_IN which_WDT equilibrium_NN is_VBZ attained_VBN ._. The_DT initial_JJ
          decay_NN of_IN mutant_JJ genomes_NNS is_VBZ identical_JJ for_IN our_PRP$ model_NN at_IN low_JJ
          m_NN ._. o_NN ._. i_NNP ._. and_CC for_IN the_DT standard_JJ quasispecies_NNS model_NN ._.
        
      
      
        Discussion_NNP
        Ruíz-_NNP Jarabo_NNP et_CC al_NN ._. measured_VBD the_DT frequency_NN of_IN the_DT
        minority_NN FMDV_NNP RED_NNP mutant_JJ up_IN to_TO passage_NN 50_CD ,_, and_CC found_VBD that_IN
        the_DT frequency_NN was_VBD still_RB declining_VBG at_IN passage_NN 50_CD [_NN 44_CD ]_NN ._.
        They_PRP observed_VBD mutant_JJ frequencies_NNS at_IN passage_NN 50_CD between_IN 6_CD ._. 6_CD
        ×_NN 10_CD -_: 4_CD and_CC 10_CD -_: 3_CD ._. These_DT results_NNS are_VBP in_IN agreement_NN with_IN our_PRP$
        model_NN of_IN phenotypic_JJ hiding_NN if_IN we_PRP use_VBP a_DT relative_JJ fitness_NN of_IN
        0_CD ._. 4_CD for_IN the_DT RED_NNP mutant_JJ as_IN compared_VBN to_TO the_DT wild_JJ type_NN [_NN 42_CD 44_CD
        ]_NN ,_, and_CC assume_VB that_IN (_( 1_LS )_) the_DT fitness_NN disadvantage_NN is_VBZ fully_RB
        explained_VBN by_IN impaired_VBN entry_NN ,_, (_( 2_LS )_) the_DT mutation_NN rate_NN is_VBZ μ_NN =_SYM
        10_CD -_: 4_CD ,_, and_CC (_( 3_LS )_) the_DT m_NN ._. o_NN ._. i_NNP ._. is_VBZ approximately_RB five_CD (_( Fig_NNP ._. 4_LS )_) ._.
        The_DT m_NN ._. o_NN ._. i_NNP ._. in_IN Ref_NNP ._. [_NN 44_CD ]_NN was_VBD between_IN one_CD and_CC five_CD ._.
        Ruíz-_NNP Jarabo_NNP et_CC al_NN ._. noted_VBD that_IN mutant_JJ concentrations_NNS around_IN
        10_CD -_: 3_CD would_MD follow_VB from_IN equilibrium_NN state_NN of_IN the_DT standard_JJ
        quasispecies_NNS model_NN if_IN the_DT mutation_NN rate_NN were_VBD μ_NN =_SYM 10_CD
        -_: 3_CD rather_RB than_IN μ_NN =_SYM 10_CD -_: 4_CD ._. However_RB ,_, the_DT standard_JJ quasispecies_NNS
        model_NN predicts_VBZ that_IN the_DT mutation-selection_JJ balance_NN should_MD
        be_VB reached_VBN around_IN passage_NN 10_CD (_( Fig_NNP ._. 4_LS )_) ,_, which_WDT is_VBZ at_IN odds_NNS
        with_IN the_DT observation_NN that_IN the_DT frequency_NN of_IN RED_NNP mutants_NNS
        continued_VBD to_TO decline_VB up_IN to_TO passage_NN 50_CD ._.
        It_PRP is_VBZ important_JJ to_TO note_VB that_IN capsid_NN proteins_NNS can_MD be_VB
        provided_VBN in_IN trans_NNS during_IN the_DT production_NN of_IN infectious_JJ FMDV_NNP
        particles_NNS [_NN 51_CD ]_NN ,_, and_CC phenotypic_JJ hiding_NN has_VBZ been_VBN known_VBN for_IN
        many_JJ years_NNS in_IN a_DT variety_NN of_IN picornaviruses_NNS [_NN 56_CD 57_CD 58_CD ]_NN ._.
        Other_JJ factors_NNS may_MD enhance_VB or_CC reduce_VB the_DT effects_NNS of_IN
        complementation_NN ._. For_IN instance_NN ,_, compartimentalization_NN or_CC
        physical_JJ localization_NN should_MD prevent_VB to_TO some_DT degree_NN the_DT
        free_JJ exchange_NN of_IN genomes_NNS and_CC products_NNS ._.
        In_IN order_NN to_TO test_VB fully_RB the_DT predictions_NNS of_IN our_PRP$ model_NN ,_, we_PRP
        would_MD need_VB data_NNS on_IN the_DT decay_NN of_IN the_DT mutant_JJ frequency_NN from_IN
        replicate_VB populations_NNS propagated_JJ at_IN different_JJ m_NN ._. o_NN ._. i_NNP ._.
        Unfortunately_RB ,_, such_JJ data_NNS does_VBZ not_RB exist_VB ._. Although_IN
        Ruíz-_NNP Jarabo_NNP et_CC al_NN ._. propagated_JJ their_PRP$ populations_NNS at_IN an_DT
        m_NN ._. o_NN ._. i_NNP ._. of_IN 0_CD ._. 1_CD in_IN their_PRP$ initial_JJ study_NN [_NN 42_CD ]_NN and_CC at_IN an_DT
        m_NN ._. o_NN ._. i_NNP ._. between_IN one_CD and_CC five_CD in_IN their_PRP$ follow-up_JJ study_NN [_NN 44_CD ]_NN
        ,_, we_PRP cannot_NN compare_VBP the_DT mutant_JJ frequencies_NNS reported_VBD in_IN
        these_DT two_CD studies_NNS ,_, because_IN the_DT method_NN of_IN screening_NN for_IN RED_NNP
        mutants_NNS was_VBD changed_VBN in_IN the_DT follow-up_JJ study_NN (_( [_NN 44_CD ]_NN ,_, Table_NNP
        1_CD ,_, Note_VB b_SYM )_) ._. Moreover_RB ,_, a_DT caveat_NN applies_VBZ to_TO the_DT comparison_NN of_IN
        the_DT experimental_JJ data_NN to_TO our_PRP$ model_NN :_: Ruíz-_NNP Jarabo_NNP et_CC al_NN ._.
        determined_VBD the_DT frequency_NN of_IN RED_NNP mutants_NNS by_IN first_JJ screening_NN
        for_IN monoclonal_NN antibody_NN (_( MAb_NNP SD_NNP 6_CD )_) resistant_JJ virions_NNS ,_, and_CC
        then_RB determining_VBG the_DT fraction_NN of_IN RED_NNP mutants_NNS among_IN them_PRP
        from_IN sequence_NN data_NNS ._. While_IN this_DT method_NN successfully_RB prevents_VBZ
        against_IN counting_VBG MAb-resistant_NNP mutants_NNS that_WDT are_VBP not_RB RED_NNP ,_, it_PRP
        does_VBZ not_RB measure_VB the_DT fraction_NN of_IN RED_NNP mutants_NNS that_WDT hide_VB
        behind_IN RGD_NNP capsids_NNS ._. If_IN phenotypic_JJ hiding_NN plays_VBZ an_DT important_JJ
        role_NN in_IN this_DT system_NN ,_, then_RB the_DT fraction_NN of_IN hiding_VBG RED_NNP
        mutants_NNS could_MD be_VB substantial_JJ ,_, and_CC the_DT reported_VBD mutant_JJ
        frequencies_NNS would_MD likely_RB represent_VB underestimates_NNS ._. In_IN
        summary_NN ,_, the_DT experimental_JJ data_NN are_VBP consistent_JJ with_IN our_PRP$
        model_NN ,_, but_CC do_VBP not_RB allow_VB us_PRP to_TO either_CC accept_VB or_CC reject_VB it_PRP
        with_IN certainty_NN ._. We_PRP have_VBP shown_VBN in_IN the_DT present_JJ paper_NN that_IN
        phenotypic_JJ hiding_NN can_MD increase_VB equilibrium_NN frequencies_NNS by_IN
        factors_NNS of_IN two_CD to_TO five_CD ,_, or_CC even_RB higher_JJR ,_, for_IN high_JJ m_NN ._. o_NN ._. i_NNP ._. It_PRP
        is_VBZ conceivable_JJ that_IN other_JJ types_NNS of_IN complementation_NN can_MD have_VB
        similar_JJ effects_NNS [_NN 59_CD ]_NN ._.
        Phenotypic_NNP hiding_VBG can_MD bias_NN fitness_NN determinations_NNS if_IN the_DT
        phenotype_NN ,_, rather_RB than_IN the_DT genotype_NN ,_, is_VBZ quantified_VBN ._. This_DT
        bias_NN occurs_VBZ simply_RB because_IN a_DT fraction_NN of_IN mutant_JJ genomes_NNS
        will_MD hide_VB behind_IN wild-type_JJ envelopes_NNS and_CC will_MD be_VB missed_VBN ,_, an_DT
        effect_NN that_WDT has_VBZ been_VBN previously_RB reported_VBN [_NN 29_CD 60_CD ]_NN ._. As_IN a_DT
        byproduct_NN of_IN our_PRP$ study_NN ,_, we_PRP predict_VBP two_CD phases_NNS of_IN mutant_JJ
        frequency_NN decay_NN specific_JJ to_TO phenotypic_JJ hiding_NN ._. In_IN the_DT first_JJ
        round_NN of_IN infection_NN ,_, all_DT virions_NNS are_VBP pure_JJ wild_JJ type_NN or_CC pure_JJ
        mutant_JJ ,_, so_IN that_IN the_DT mutant_JJ virions_NNS cannot_NN benefit_NN from_IN
        complementation_NN ._. Therefore_RB ,_, their_PRP$ frequency_NN will_MD decrease_VB
        corresponding_JJ to_TO their_PRP$ true_JJ fitness_NN and_CC independently_RB of_IN
        the_DT m_NN ._. o_NN ._. i_NNP ._. From_IN the_DT second_JJ passage_NN onward_NN ,_, the_DT balance_NN
        between_IN pure_JJ and_CC mixed_JJ virions_NNS is_VBZ established_VBN ,_, and_CC further_JJ
        reduction_NN of_IN the_DT mutant_JJ frequency_NN proceeds_NNS much_RB slower_JJR if_IN
        the_DT m_NN ._. o_NN ._. i_NNP ._. is_VBZ sufficiently_RB high_JJ ,_, as_IN illustrated_VBN in_IN Figure_NN
        2_CD ._. As_IN a_DT consequence_NN ,_, if_IN fitness_NN competitions_NNS are_VBP halted_VBN
        after_IN the_DT first_JJ passage_NN ,_, measurements_NNS of_IN the_DT phenotype_NN will_MD
        not_RB bias_NN fitness_NN determinations_NNS ._. These_DT effect_NN should_MD not_RB be_VB
        observed_VBN in_IN other_JJ forms_NNS of_IN complementation_NN ,_, but_CC should_MD be_VB
        characteristic_NN of_IN any_DT situation_NN in_IN which_WDT the_DT phenotype_NN is_VBZ
        determined_VBN by_IN envelope_NN proteins_NNS ._. Host_NN range_NN will_MD often_RB
        belong_VB to_TO this_DT category_NN ,_, since_IN receptor_NN recognition_NN is_VBZ one_CD
        of_IN its_PRP$ main_JJ determinants_NNS ._. Other_JJ examples_NNS include_VBP antibody_NN
        resistant_JJ mutants_NNS and_CC escape_VB mutants_NNS when_WRB the_DT antiviral_JJ
        drug_NN targets_NNS entry_NN ,_, such_JJ as_IN rimantidine_NN and_CC
        amantidine-resistant_JJ influenza_NN strains_NNS or_CC WIN_NNP
        compound-resistant_JJ picornaviruses_NNS [_NN 61_CD ]_NN ._. Thus_RB ,_, phenotypic_JJ
        hiding_NN can_MD keep_VB a_DT relatively_RB large_JJ frequency_NN of_IN mutants_NNS in_IN
        the_DT absence_NN of_IN selective_JJ pressure_NN that_WDT can_MD provide_VB a_DT quick_JJ
        response_NN when_WRB such_JJ selective_JJ pressure_NN is_VBZ restored_VBN ._.
        Complementation_NNP can_MD also_RB complicate_VB the_DT interpretation_NN
        of_IN other_JJ experimental_JJ results_NNS involving_VBG competition_NN between_IN
        two_CD (_( or_CC more_JJR )_) strains_NNS ._. For_IN instance_NN ,_, Miralles_NNP et_CC al_NN ._. [_NN 62_CD
        63_CD ]_NN tested_VBD the_DT effect_NN of_IN clonal_NN interference_NN in_IN VSV_NNP
        populations_NNS by_IN changing_VBG the_DT population_NN size_NN in_IN competitions_NNS
        between_IN wild_JJ type_NN and_CC a_DT MARM_NNP mutant_JJ ._. This_DT MARM_NNP mutant_JJ
        carries_VBZ a_DT point_NN mutation_NN that_WDT confers_VBZ resistance_NN to_TO I_PRP 1_CD Mab_NNP ,_,
        but_CC it_PRP is_VBZ neutral_JJ otherwise_RB [_NN 64_CD ]_NN ._. Clonal_NNP interference_NN
        occurs_VBZ in_IN asexual_NN organisms_NNS when_WRB population_NN sizes_NNS are_VBP large_JJ
        enough_RB to_TO allow_VB the_DT simultaneous_JJ generation_NN of_IN more_JJR than_IN
        one_CD advantageous_JJ mutation_NN ,_, so_IN that_IN the_DT best_JJS mutation_NN has_VBZ to_TO
        compete_VB not_RB only_RB with_IN an_DT inferior_JJ wild_JJ type_NN but_CC also_RB with_IN
        the_DT other_JJ fitter_NN mutants_NNS [_NN 65_CD ]_NN ._. Thus_RB ,_, while_IN the_DT best_JJS
        possible_JJ mutation_NN should_MD always_RB be_VB the_DT one_CD becoming_VBG
        dominant_JJ ,_, the_DT rate_NN at_IN which_WDT it_PRP does_VBZ so_RB should_MD be_VB slowed_VBN
        down_RB in_IN large_JJ populations_NNS ._. The_DT VSV_NNP competition_NN experiments_NNS
        were_VBD carried_VBN out_RB at_IN increasing_VBG viral_JJ population_NN sizes_NNS ,_, but_CC
        the_DT number_NN of_IN infected_JJ cells_NNS was_VBD held_VBN constant_JJ ,_, that_WDT is_VBZ ,_,
        the_DT m_NN ._. o_NN ._. i_NNP ._. was_VBD increased_VBN alongside_IN the_DT population_NN size_NN ._.
        Therefore_RB ,_, complementation_NN may_MD also_RB have_VB contributed_VBN to_TO the_DT
        slowdown_NN of_IN the_DT speed_NN of_IN adaptation_NN at_IN large_JJ population_NN
        sizes_NNS ,_, and_CC the_DT relative_JJ contributions_NNS of_IN complementation_NN
        and_CC clonal_NN interference_NN to_TO the_DT slowdown_NN would_MD be_VB hard_JJ to_TO
        disentangle_NN ._. The_DT only_RB phenotypic_JJ hiding_NN effect_NN that_IN the_DT
        authors_NNS could_MD avoid_VB were_VB related_VBN to_TO the_DT determination_NN of_IN
        changes_NNS in_IN MARM_NNP C_NNP frequencies_NNS ,_, and_CC these_DT only_RB correlate_VBP to_TO
        the_DT changes_NNS in_IN beneficial_JJ mutation_NN frequencies_NNS if_IN the_DT
        beneficial_JJ mutation_NN mapped_VBN to_TO the_DT G_NNP glycoprotein_NN ._.
        Many_JJ infections_NNS in_IN plants_NNS and_CC animals_NNS are_VBP probably_RB
        initiated_VBN by_IN one_CD or_CC few_JJ viral_JJ particles_NNS ,_, thus_RB corresponding_JJ
        to_TO a_DT situation_NN of_IN low_JJ m_NN ._. o_NN ._. i_NNP ._. As_IN replication_NN proceeds_NNS and_CC
        titers_NNS rise_NN ,_, the_DT likelyhood_NN of_IN coinfection_NN increases_NNS ._. The_DT
        best_JJS evidence_NN for_IN multiple_JJ infections_NNS 
        in_IN vivo_NN comes_VBZ from_IN the_DT observation_NN of_IN
        natural_JJ recombinants_NNS ._. In_IN the_DT case_NN of_IN HIV-_NNP 1_CD ,_, for_IN instance_NN ,_,
        rampant_JJ recombination_NN has_VBZ been_VBN reported_VBN ,_, even_RB among_IN
        different_JJ subtypes_NNS [_NN 66_CD 67_CD ]_NN ,_, and_CC the_DT number_NN of_IN proviruses_NNS
        per_IN cell_NN was_VBD estimated_VBN to_TO be_VB approximately_RB three_CD ._. Another_DT
        well_RB known_VBN example_NN is_VBZ influenza_NN virus_NN ,_, for_IN which_WDT
        reassortment_NN is_VBZ a_DT major_JJ mechanism_NN of_IN evolutionary_JJ change_NN [_NN
        68_CD ]_NN ._. As_IN in_IN the_DT case_NN of_IN HIV_NNP ,_, reassortment_NN depends_VBZ of_IN
        coinfection_NN ,_, and_CC once_RB coinfection_NN occurs_VBZ ,_, complementation_NN
        is_VBZ as_IN likely_JJ to_TO ensue_VB as_IN reassortment_NN ._.
      
      
        Conclusions_NNP
        We_PRP have_VBP shown_VBN that_IN phenotypic_JJ hiding_NN has_VBZ substantial_JJ
        influence_NN on_IN the_DT equilibrium_NN frequencies_NNS of_IN mutants_NNS in_IN
        selection-mutation_JJ balance_NN ,_, and_CC on_IN the_DT speed_NN at_IN which_WDT
        deleterious_JJ mutants_NNS are_VBP lost_VBN from_IN the_DT population_NN ._. Our_PRP$
        theory_NN makes_VBZ five_CD predictions_NNS that_WDT can_MD be_VB tested_VBN
        experimentally_RB :_:
        1_LS ._. The_DT rate_NN at_IN which_WDT the_DT mutant_JJ disappears_VBZ should_MD
        decrease_VB and_CC the_DT equilibrium_NN concentration_NN of_IN the_DT mutant_JJ
        should_MD increase_VB with_IN increasing_VBG m_NN ._. o_NN ._. i_NNP ._.
        2_LS ._. A_DT substantial_JJ fraction_NN of_IN mutant_JJ genomes_NNS should_MD be_VB
        encapsidated_JJ with_IN wild-type_JJ protein_NN ._.
        3_LS ._. The_DT ratio_NN of_IN mutant_JJ genomes_NNS encapsidated_JJ in_IN wild-type_JJ
        protein_NN to_TO wild-type_JJ genomes_NNS encapsidated_JJ in_IN mutant_JJ protein_NN
        should_MD decrease_VB with_IN increasing_VBG m_NN ._. o_NN ._. i_NNP ._.
        4_LS ._. Even_RB at_IN low_JJ m_NN ._. o_NN ._. i_NNP ._. ,_, the_DT fraction_NN of_IN mutant_JJ present_NN in_IN
        mutation-selection_JJ balance_NN should_MD be_VB larger_JJR (_( up_IN to_TO a_DT factor_NN
        of_IN two_CD )_) than_IN predicted_VBN by_IN the_DT standard_JJ quasispecies_NNS model_NN
        if_IN the_DT mutant_JJ fitness_NN is_VBZ low_JJ compared_VBN to_TO the_DT wild-type_JJ
        fitness_NN ._.
        5_LS ._. The_DT decrease_NN of_IN mutant_JJ frequency_NN during_IN the_DT first_JJ
        passage_NN should_MD be_VB independent_JJ of_IN the_DT m_NN ._. o_NN ._. i_NNP ._. ,_, and_CC equal_JJ to_TO
        that_DT measured_VBD for_IN later_JJ passages_NNS at_IN very_RB low_JJ m_NN ._. o_NN ._. i_NNP ._.
        Future_JJ experiments_NNS can_MD be_VB designed_VBN to_TO test_VB these_DT
        predictions_NNS ,_, and_CC can_MD thereby_RB clarify_VB whether_IN phenotypic_JJ
        hiding_NN is_VBZ a_DT major_JJ contributor_NN to_TO viral_JJ memory_NN and_CC elevated_VBD
        equilibrium_NN frequencies_NNS of_IN mutants_NNS ._.
      
      
        Methods_NNP
        In_IN this_DT section_NN ,_, we_PRP present_VB some_DT calculations_NNS that_WDT form_NN
        the_DT basis_NN of_IN the_DT derivation_NN of_IN our_PRP$ model_NN equations_NNS ._.
        We_PRP first_JJ calculate_VB the_DT probability_NN that_IN a_DT virion_NN
        produced_VBN by_IN an_DT 
        n_NN -_: fold_VB coinfected_JJ cell_NN is_VBZ pure_JJ ._.
        Assume_VB a_DT cell_NN is_VBZ infected_VBN by_IN 
        k_NN virions_NNS with_IN wild-type_JJ genotype_NN ,_,
        and_CC by_IN 
        n_NN -_: 
        k_NN virions_NNS with_IN mutant_JJ genotype_NN ._. Then_RB ,_,
        the_DT probability_NN that_IN an_DT offspring_NN virion_NN is_VBZ pure_JJ wild-type_JJ
        is_VBZ the_DT probability_NN that_IN it_PRP has_VBZ wild-type_JJ genotype_NN ,_, which_WDT is_VBZ
        
        k_NN /_NN 
        n_NN ,_, times_NNS the_DT probability_NN that_IN it_PRP has_VBZ
        wild-type_JJ phenotype_NN ,_, which_WDT is_VBZ again_RB 
        k_NN /_NN 
        n_NN ._. Thus_RB ,_, the_DT total_JJ probability_NN is_VBZ (_( 
        k_NN /_NN 
        n_NN )_) 2_CD ._. If_IN we_PRP want_VBP to_TO know_VB the_DT
        probability_NN that_IN an_DT offspring_NN virion_NN is_VBZ pure_JJ for_IN a_DT number_NN
        of_IN coinfected_JJ cells_NNS with_IN different_JJ ratios_NNS in_IN their_PRP$
        multiplicity_NN of_IN infection_NN of_IN wild-type_JJ and_CC mutant_JJ
        genotypes_NNS ,_, then_RB we_PRP have_VBP to_TO sum_VB over_IN the_DT different_JJ
        contributions_NNS of_IN all_PDT the_DT individual_JJ cells_NNS ._. In_IN practice_NN ,_, we_PRP
        will_MD not_RB know_VB exactly_RB which_WDT cells_NNS are_VBP infected_VBN with_IN what_WP
        virions_NNS ._. However_RB ,_, it_PRP is_VBZ reasonable_JJ to_TO assume_VB that_IN we_PRP know_VBP
        the_DT overall_JJ probabilities_NNS with_IN which_WDT cells_NNS are_VBP infected_VBN
        with_IN either_DT mutant_JJ or_CC wild-type_JJ genotype_NN ._. Assume_VB that_DT 
        x_SYM 
        
          w_NN 
         is_VBZ the_DT probability_NN that_IN a_DT cell_NN is_VBZ infected_VBN with_IN
        wild-type_JJ genotype_NN ,_, and_CC 
        x_SYM 
        
          m_NN 
         =_SYM 1_CD -_: 
        x_SYM 
        
          w_NN 
         likewise_RB for_IN the_DT mutant_JJ genotype_NN ._. Then_RB ,_, the_DT number_NN of_IN
        wild-type_JJ genomes_NNS 
        k_NN in_IN a_DT cell_NN is_VBZ binomially_RB
        distributed_VBN ,_, and_CC therefore_RB the_DT overall_JJ probability_NN ξ_NN 
        
          ww_NN 
         (_( 
        n_NN )_) that_IN an_DT offspring_NN virion_NN from_IN a_DT
        cell_NN infected_VBN by_IN 
        n_NN virions_NNS is_VBZ pure_JJ wild-type_JJ becomes_VBZ [_NN
        38_CD ]_NN
        
        Likewise_RB ,_, we_PRP find_VBP for_IN the_DT probability_NN ξ_NN 
        
          mm_NN 
         (_( 
        n_NN )_) that_IN an_DT offspring_NN virion_NN is_VBZ pure_JJ
        mutant_JJ ξ_NN 
        
          mm_NN 
         (_( 
        n_NN )_) =_SYM 
        x_SYM 
        
          w_NN 
         
        x_SYM 
        
          m_NN 
         /_NN 
        n_NN +_NN ._.
        Now_RB we_PRP consider_VBP mixed_JJ virions_NNS ._. Assume_VB again_RB that_IN a_DT cell_NN
        is_VBZ infected_VBN by_IN 
        k_NN virions_NNS with_IN wild-type_JJ genotype_NN ,_,
        and_CC by_IN 
        n_NN -_: 
        k_NN virions_NNS with_IN mutant_JJ genotype_NN ._. In_IN
        analogy_NN to_TO the_DT considerations_NNS for_IN a_DT pure_JJ virion_NN ,_, we_PRP find_VBP
        that_IN the_DT probability_NN of_IN a_DT mixed_JJ virion_NN is_VBZ 
        k_NN (_( 
        n_NN -_: 
        k_NN )_) /_NN 
        n_NN 2_CD ,_, regardless_RB of_IN whether_IN the_DT
        genotype_NN is_VBZ wild-type_JJ and_CC the_DT phenotype_NN is_VBZ mutant_JJ or_CC vice_NN
        versa_RB ._. The_DT probabilities_NNS ξ_NN 
        
          wm_NN 
         (_( 
        n_NN )_) and_CC ξ_NN 
        
          mw_NN 
         (_( 
        n_NN )_) that_IN an_DT offspring_NN virion_NN is_VBZ mixed_VBN
        of_IN either_DT type_NN are_VBP then_RB
        
        Equations_NNP (_( 9_CD )_) and_CC (_( 10_CD )_) are_VBP valid_JJ if_IN all_DT cells_NNS have_VBP
        exactly_RB the_DT same_JJ multiplicity_NN of_IN infection_NN ._. However_RB ,_,
        infection_NN is_VBZ a_DT Poisson_NNP process_NN ,_, and_CC some_DT cells_NNS will_MD end_VB up_RP
        being_VBG infected_VBN by_IN more_JJR virions_NNS than_IN other_JJ cells_NNS ._. Assume_VB
        that_DT λ_NN is_VBZ the_DT multiplicity_NN of_IN infection_NN of_IN the_DT whole_JJ
        population_NN ._. Then_RB ,_, the_DT probability_NN that_IN a_DT single_JJ infected_JJ
        cell_NN is_VBZ infected_VBN by_IN 
        k_NN virions_NNS is_VBZ 
        e_SYM -_: λλ_NN 
        k_NN /_NN [_NN (_( 1_CD -_: 
        e_SYM -_: λ_NN )_) 
        k_NN !_. ]_NN ._. The_DT factor_NN 1_CD -_: 
        e_SYM -_: λin_NN the_DT denominator_NN corrects_VBZ for_IN
        the_DT 
        e_SYM -_: λcells_NNS that_WDT will_MD not_RB be_VB infected_JJ
        at_IN all_DT ._. We_PRP obtain_VBP the_DT overall_JJ probabilities_NNS to_TO find_VB a_DT pure_JJ
        or_CC mixed_JJ offspring_NN virion_NN by_IN summing_VBG over_IN all_DT possible_JJ
        combinations_NNS of_IN infections_NNS ,_, with_IN their_PRP$ respective_JJ
        probabilities_NNS ._. For_IN example_NN :_:
        
        After_IN taking_VBG the_DT sum_NN ,_, we_PRP find_VBP :_:
        
        p_NN 
        
          ww_NN 
         =_SYM +_NN 
        cx_NN 
        
          w_NN 
         
        x_SYM 
        
          m_NN 
         ,_, (_( 12_CD )_)
        where_WRB the_DT constant_JJ 
        c_SYM is_VBZ given_VBN by_IN
        
        Here_RB ,_, Ei_NNP (_( 
        z_SYM )_) is_VBZ the_DT exponential_NN integral_JJ ,_, ,_,
        and_CC γ_NN is_VBZ the_DT Euler_NNP constant_JJ ,_, γ_NN ≈_NN 0_CD ._. 577216_CD ._. Finally_RB ,_, by_IN
        making_VBG use_NN of_IN 
        x_SYM 
        
          w_NN 
         =_SYM 1_CD -_: 
        x_SYM 
        
          m_NN 
         ;_: we_PRP arrive_VBP at_IN
        
        p_NN 
        
          mm_NN 
         =_SYM 
        cx_NN 
        
          w_NN 
         +_NN (_( 1_CD -_: 
        c_SYM )_) ._. (_( 14_CD )_)
        Similarly_RB ,_, for_IN a_DT mixed_JJ virion_NN ,_, we_PRP find_VBP
        
        We_PRP obtain_VBP 
        p_NN 
        
          mm_NN 
         and_CC 
        p_NN 
        
          mw_NN 
         from_IN Eqs_NNP ._. (_( 14_CD )_) and_CC (_( 15_CD )_) by_IN interchanging_VBG w_NN and_CC m_NN in_IN
        all_DT subscripts_NNS ._. Equations_NNP (_( 14_CD )_) and_CC (_( 15_CD )_) show_NN that_IN the_DT
        mixing_VBG parameter_NN 
        r_LS used_VBN in_IN the_DT main_JJ body_NN of_IN this_DT paper_NN
        is_VBZ related_VBN to_TO 
        c_SYM via_IN 
        r_LS =_SYM 1_CD -_: 
        c_SYM ._.
      
      
        Authors_NNP '_'' contributions_NNS
        COW_NNP was_VBD responsible_JJ for_IN the_DT analytic_JJ calculations_NNS ._. Both_DT
        authors_NNS contributed_VBD substantially_RB to_TO the_DT design_NN of_IN the_DT
        study_NN and_CC the_DT writing_NN of_IN the_DT manuscript_NN ._. Both_DT authors_NNS read_VBP
        and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
